ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Concord Medical Reports Financial Results for the First Half of 2020
August 26, 2020Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalo -
Recommendations Decreased for Cough, Cold Medicine in U.S.
August 02, 2019There has been a decrease in recommendations for opioid-containing and nonopioid cough and cold medicines (CCM) in the United States... -
Recursion Receives FDA Clearance for REC-994 Clinical Trial
July 11, 2018Recursion announced the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a Phase 1 clinical trial of REC-994 in the treatment of cerebral cavernous malformation (CCM).
Pharma Sources Insight January 2025
